Last reviewed · How we verify

Curcumin Lozenges — Competitive Intelligence Brief

Curcumin Lozenges (Curcumin Lozenges) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural product/polyphenol anti-inflammatory agent. Area: Oncology, Oral health, Anti-inflammatory.

phase 3 Natural product/polyphenol anti-inflammatory agent NF-κB, multiple antioxidant pathways Oncology, Oral health, Anti-inflammatory Small molecule Live · refreshed every 30 min

Target snapshot

Curcumin Lozenges (Curcumin Lozenges) — Tata Memorial Centre. Curcumin, the active compound from turmeric, exerts anti-inflammatory and antioxidant effects by inhibiting NF-κB signaling and reducing pro-inflammatory cytokine production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Curcumin Lozenges TARGET Curcumin Lozenges Tata Memorial Centre phase 3 Natural product/polyphenol anti-inflammatory agent NF-κB, multiple antioxidant pathways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural product/polyphenol anti-inflammatory agent class)

  1. Tata Memorial Centre · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Curcumin Lozenges — Competitive Intelligence Brief. https://druglandscape.com/ci/curcumin-lozenges. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: